Header Logo

Connection

STEPHEN PATRICK to Female

Back to Details
This is a "connection" page, showing publications STEPHEN PATRICK has written about Female.
STEPHEN PATRICK
Connection Strength
1.760
Female
  1. A taxonomy of states' approaches to plans of safe care. Child Abuse Negl. 2026 Aug; 178:108169.
    View in: PubMed
    Score: 0.037
  2. A Policy Scan on Plans of Safe Care for Infants With Prenatal Substance Exposure. Hosp Pediatr. 2025 Dec 01; 15(12):1039-1047.
    View in: PubMed
    Score: 0.035
  3. Cost-Effectiveness of Treatment for Opioid Use Disorder in Pregnancy and Its Impact on Birth Outcomes. JAMA Pediatr. 2025 Nov 01; 179(11):1203-1216.
    View in: PubMed
    Score: 0.035
  4. Buprenorphine Treatment in Pregnancy and Maternal-Infant Outcomes. JAMA Health Forum. 2025 04 27; 6(4.11):e251814.
    View in: PubMed
    Score: 0.034
  5. Adapting a Risk Prediction Tool for Neonatal Opioid Withdrawal Syndrome. Pediatrics. 2025 Apr 01; 155(4).
    View in: PubMed
    Score: 0.034
  6. "Just Google It": A Qualitative Study of Reproductive-Age Women's Stigmatizing Experiences When Accessing Buprenorphine for Opioid Use Disorder. Womens Health Issues. 2025 Jan-Feb; 35(1):45-53.
    View in: PubMed
    Score: 0.033
  7. Sex and Gender Variables in Data Set Creation and Data Cleaning for Inclusive and Accurate Reproductive Health Research and Quality Improvement. J Midwifery Womens Health. 2025 Jan-Feb; 70(1):131-136.
    View in: PubMed
    Score: 0.033
  8. Voter Support for Policies Associated With Child Health as National Campaign Priorities. JAMA Health Forum. 2024 09 06; 5(9):e243305.
    View in: PubMed
    Score: 0.032
  9. Hospital Quality Indicators for Opioid-Exposed Infants: Results From an Expert Consensus Panel. Pediatrics. 2024 Jul 01; 154(1).
    View in: PubMed
    Score: 0.032
  10. Performance of Phenotype Algorithms for the Identification of Opioid-Exposed Infants. Hosp Pediatr. 2024 06 01; 14(6):438-447.
    View in: PubMed
    Score: 0.032
  11. County-Level Atrazine Use and Gastroschisis. JAMA Netw Open. 2024 05 01; 7(5):e2410056.
    View in: PubMed
    Score: 0.032
  12. Medications for Opioid Use Disorder During the Prenatal Period and Infant Outcomes. JAMA Pediatr. 2023 11 01; 177(11):1228-1230.
    View in: PubMed
    Score: 0.031
  13. County-level Factors and Treatment Access Among Insured Women With Opioid Use Disorder. Med Care. 2023 12 01; 61(12):816-821.
    View in: PubMed
    Score: 0.030
  14. Prevalence of Buprenorphine Providers Requiring Cash Payment From Insured Women Seeking Opioid Use Disorder Treatment. Med Care. 2023 06 01; 61(6):377-383.
    View in: PubMed
    Score: 0.030
  15. Trends in Neonatal Extracorporeal Membrane Oxygenation During a Venovenous Cannula Shortage. Pediatr Crit Care Med. 2023 03 01; 24(3):245-250.
    View in: PubMed
    Score: 0.029
  16. Laws Forbidding Pregnancy Discrimination in Substance Use Disorder Treatment Are Not Associated With Treatment Access. J Addict Med. 2022 May-Jun 01; 16(3):364-367.
    View in: PubMed
    Score: 0.028
  17. Medicaid prevalence and opioid use disorder treatment access disparities. Health Serv Res. 2022 04; 57(2):422-429.
    View in: PubMed
    Score: 0.027
  18. Association of Individual and Community Factors With Hepatitis C Infections Among Pregnant People and Newborns. JAMA Health Forum. 2021 10; 2(10):e213470.
    View in: PubMed
    Score: 0.027
  19. Changes in Use of Respiratory Support for Preterm Infants in the US, 2008-2018. JAMA Pediatr. 2021 10 01; 175(10):1017-1024.
    View in: PubMed
    Score: 0.027
  20. Impact of stigmatizing language describing opioid-exposed mother infant dyads: A randomized case vignette study. Subst Abus. 2022; 43(1):551-555.
    View in: PubMed
    Score: 0.027
  21. Neonatal Abstinence Syndrome and Maternal Opioid-Related Diagnoses: Analysis of ICD-10-CM Transition, 2013-2017. Hosp Pediatr. 2021 08; 11(8):902-908.
    View in: PubMed
    Score: 0.026
  22. Disparities in receipt of medications for opioid use disorder among pregnant women. Subst Abus. 2022; 43(1):508-513.
    View in: PubMed
    Score: 0.026
  23. Reproductive-Age Women's Experience of Accessing Treatment for Opioid Use Disorder: "We Don't Do That Here". Womens Health Issues. 2021 Sep-Oct; 31(5):455-461.
    View in: PubMed
    Score: 0.026
  24. Association of Preterm Birth Rate With COVID-19 Statewide Stay-at-Home Orders in Tennessee. JAMA Pediatr. 2021 Jun 01; 175(6):635-637.
    View in: PubMed
    Score: 0.026
  25. US Hospital Data About Neonatal Abstinence Syndrome and Maternal Opioid-Related Diagnoses-Reply. JAMA. 2021 05 25; 325(20):2120.
    View in: PubMed
    Score: 0.026
  26. Neonatal Abstinence Syndrome and Maternal Opioid-Related Diagnoses in the US, 2010-2017. JAMA. 2021 01 12; 325(2):146-155.
    View in: PubMed
    Score: 0.025
  27. Evaluating Definitions for Neonatal Abstinence Syndrome. Pediatrics. 2021 01; 147(1).
    View in: PubMed
    Score: 0.025
  28. Neonatal Opioid Withdrawal Syndrome. Pediatrics. 2020 11; 146(5).
    View in: PubMed
    Score: 0.025
  29. Development and Validation of a Model to Predict Neonatal Abstinence Syndrome. J Pediatr. 2021 02; 229:154-160.e6.
    View in: PubMed
    Score: 0.025
  30. Association of Pregnancy and Insurance Status With Treatment Access for Opioid Use Disorder. JAMA Netw Open. 2020 08 03; 3(8):e2013456.
    View in: PubMed
    Score: 0.024
  31. Well-being of Parents and Children During the COVID-19 Pandemic: A National Survey. Pediatrics. 2020 10; 146(4).
    View in: PubMed
    Score: 0.024
  32. Medications for opioid use disorder among pregnant women referred by criminal justice agencies before and after Medicaid expansion: A retrospective study of admissions to treatment centers in the United States. PLoS Med. 2020 05; 17(5):e1003119.
    View in: PubMed
    Score: 0.024
  33. Neonatal Abstinence Syndrome In The United States, 2004-16. Health Aff (Millwood). 2020 05; 39(5):764-767.
    View in: PubMed
    Score: 0.024
  34. Hepatitis C Testing Among Perinatally Exposed Infants. Pediatrics. 2020 03; 145(3).
    View in: PubMed
    Score: 0.024
  35. Opioid Litigation and Maternal-Child Health-Investing in the Future. JAMA Pediatr. 2020 02 01; 174(2):119-120.
    View in: PubMed
    Score: 0.024
  36. Improving the Discharge Process for Opioid-Exposed Neonates. Hosp Pediatr. 2019 08; 9(8):643-648.
    View in: PubMed
    Score: 0.023
  37. Improving the Child Welfare System to Respond to the Needs of Substance-Exposed Infants. Hosp Pediatr. 2019 08; 9(8):651-654.
    View in: PubMed
    Score: 0.023
  38. Increased Severity of Neonatal Abstinence Syndrome Associated With Concomitant Antenatal Opioid and Benzodiazepine Exposure. Hosp Pediatr. 2019 08; 9(8):569-575.
    View in: PubMed
    Score: 0.023
  39. Neonatal Abstinence Syndrome. Pediatr Clin North Am. 2019 04; 66(2):353-367.
    View in: PubMed
    Score: 0.022
  40. Association Among County-Level Economic Factors, Clinician Supply, Metropolitan or Rural Location, and Neonatal Abstinence Syndrome. JAMA. 2019 01 29; 321(4):385-393.
    View in: PubMed
    Score: 0.022
  41. Positive Predictive Value of Administrative Data for Neonatal Abstinence Syndrome. Pediatrics. 2019 01; 143(1).
    View in: PubMed
    Score: 0.022
  42. Umbilical Cord Tissue and Meconium May Not Be Equivalent for Confirming in Utero Substance Exposure. J Pediatr. 2019 02; 205:277-280.
    View in: PubMed
    Score: 0.022
  43. Barriers to accessing treatment for pregnant women with opioid use disorder in Appalachian states. Subst Abus. 2019; 40(3):356-362.
    View in: PubMed
    Score: 0.022
  44. National and regional trends in gastrostomy in very low birth weight infants in the USA: 2000-2012. J Perinatol. 2018 09; 38(9):1270-1276.
    View in: PubMed
    Score: 0.021
  45. Changing patterns of patent ductus arteriosus surgical ligation in the United States. Semin Perinatol. 2018 06; 42(4):253-261.
    View in: PubMed
    Score: 0.021
  46. Outpatient Pharmacotherapy for Neonatal Abstinence Syndrome. J Pediatr. 2018 08; 199:151-157.e1.
    View in: PubMed
    Score: 0.021
  47. Incidence and Costs of Neonatal Abstinence Syndrome Among Infants With Medicaid: 2004-2014. Pediatrics. 2018 04; 141(4).
    View in: PubMed
    Score: 0.021
  48. Prescribing opioids and psychotropic drugs in pregnancy. BMJ. 2017 08 02; 358:j3616.
    View in: PubMed
    Score: 0.020
  49. Treatment of Opioid Use Disorder During Pregnancy and Cases of Neonatal Abstinence Syndrome. JAMA Pediatr. 2017 07 01; 171(7):707.
    View in: PubMed
    Score: 0.020
  50. A Comprehensive Approach to the Opioid Epidemic. Obstet Gynecol. 2017 07; 130(1):7-9.
    View in: PubMed
    Score: 0.020
  51. Male Sex Associated With Increased Risk of Neonatal Abstinence Syndrome. Hosp Pediatr. 2017 Jun; 7(6):328-334.
    View in: PubMed
    Score: 0.020
  52. Nonmedical Use of Prescription Opioids among Pregnant U.S. Women. Womens Health Issues. 2017 May - Jun; 27(3):308-315.
    View in: PubMed
    Score: 0.019
  53. Rural and Urban Differences in Neonatal Abstinence Syndrome and Maternal Opioid Use, 2004 to 2013. JAMA Pediatr. 2017 02 01; 171(2):194-196.
    View in: PubMed
    Score: 0.019
  54. The opioid epidemic and neonatal abstinence syndrome in the USA: a review of the continuum of care. Arch Dis Child Fetal Neonatal Ed. 2017 Mar; 102(2):F183-F187.
    View in: PubMed
    Score: 0.019
  55. Opioid Use Disorder in Pregnancy: Health Policy and Practice in the Midst of an Epidemic. Obstet Gynecol. 2016 Jul; 128(1):4-10.
    View in: PubMed
    Score: 0.018
  56. Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-Related Death Rates. Health Aff (Millwood). 2016 07 01; 35(7):1324-32.
    View in: PubMed
    Score: 0.018
  57. Risk of Hospital Readmission Among Infants With Neonatal Abstinence Syndrome. Hosp Pediatr. 2015 Oct; 5(10):513-9.
    View in: PubMed
    Score: 0.017
  58. Promise and peril: Dissemination of findings from studies of drugs used in pregnancy and their association with birth defects. Birth Defects Res A Clin Mol Teratol. 2015 Aug; 103(8):729-32.
    View in: PubMed
    Score: 0.017
  59. Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012. J Perinatol. 2015 Aug; 35(8):650-5.
    View in: PubMed
    Score: 0.017
  60. Prescription opioid epidemic and infant outcomes. Pediatrics. 2015 May; 135(5):842-50.
    View in: PubMed
    Score: 0.017
  61. Health care-associated infections among critically ill children in the US, 2007-2012. Pediatrics. 2014 Oct; 134(4):705-12.
    View in: PubMed
    Score: 0.016
  62. Variation in treatment of neonatal abstinence syndrome in US children's hospitals, 2004-2011. J Perinatol. 2014 Nov; 34(11):867-72.
    View in: PubMed
    Score: 0.016
  63. Early effects of scheduling gabapentin on medication adherence among epilepsy patients on gabapentin in Virginia. Int J Drug Policy. 2026 May; 151:105233.
    View in: PubMed
    Score: 0.009
  64. Continuous Medicaid Eligibility, Child Insurance, and Health Care Use. Pediatrics. 2026 01 01; 157(1).
    View in: PubMed
    Score: 0.009
  65. Parental Health After Preterm Birth: Insights From the National Survey of Children's Health. Acad Pediatr. 2026 03; 26(2):103182.
    View in: PubMed
    Score: 0.009
  66. Adolescent Treatment Landscape of Depression, Suicidality, and Substance Use Disorder in the US. JAMA Health Forum. 2025 08 01; 6(8):e252647.
    View in: PubMed
    Score: 0.009
  67. Association of Opioid Disposal Practices with Parental Education and a Home Opioid Disposal Kit Following Pediatric Ambulatory Surgery. Anesth Analg. 2025 06 01; 140(6):1461-1469.
    View in: PubMed
    Score: 0.009
  68. Pharmacotherapy research landscape and knowledge gaps of opioids in maternal and pediatric populations. Pharmacotherapy. 2025 06; 45(6):367-385.
    View in: PubMed
    Score: 0.009
  69. Association of Opioid Use Disorder-Related Service Trajectories During Pregnancy and Postpartum Health Service Use: A Group-Based Multitrajectory Modeling Study. J Addict Med. 2025 Jul-Aug 01; 19(4):403-411.
    View in: PubMed
    Score: 0.008
  70. Consistency and Adequacy of Public and Commercial Health Insurance for US Children, 2016 to 2021. JAMA Health Forum. 2023 11 03; 4(11):e234179.
    View in: PubMed
    Score: 0.008
  71. Patient and Community Factors Affecting Treatment Access for Opioid Use Disorder. Obstet Gynecol. 2023 08 01; 142(2):339-349.
    View in: PubMed
    Score: 0.007
  72. Maternal Opioid Use Disorder and the Risk of Postneonatal Infant Mortality. JAMA Pediatr. 2023 07 01; 177(7):675-683.
    View in: PubMed
    Score: 0.007
  73. Treatment access for opioid use disorder among women with medicaid in Florida. Drug Alcohol Depend. 2023 05 01; 246:109854.
    View in: PubMed
    Score: 0.007
  74. Risk of Death at 1 Year Following Postpartum Opioid Exposure. Am J Perinatol. 2024 05; 41(7):949-960.
    View in: PubMed
    Score: 0.007
  75. Factors Associated With Parental COVID-19 Vaccination Acceptance. Clin Pediatr (Phila). 2022 06; 61(5-6):393-401.
    View in: PubMed
    Score: 0.007
  76. Assessing Stigma Towards Substance Use in Pregnancy: A Randomized Study Testing the Impact of Stigmatizing Language and Type of Opioid Use on Attitudes Toward Mothers With Opioid Use Disorder. J Addict Med. 2022 Jan-Feb 01; 16(1):77-83.
    View in: PubMed
    Score: 0.007
  77. Leftover Opioid Analgesics and Disposal Following Ambulatory Pediatric Surgeries in the Context of a Restrictive Opioid-Prescribing Policy. Anesth Analg. 2022 01 01; 134(1):133-140.
    View in: PubMed
    Score: 0.007
  78. Standardizing the Clinical Definition of Opioid Withdrawal in the Neonate. J Pediatr. 2022 04; 243:33-39.e1.
    View in: PubMed
    Score: 0.007
  79. The risk of serious opioid-related events associated with common opioid prescribing regimens in the postpartum period after cesarean delivery. Am J Obstet Gynecol MFM. 2021 11; 3(6):100475.
    View in: PubMed
    Score: 0.007
  80. Using Public Health Surveillance Data to Determine Hepatitis C Virus Exposure Among Live-Born Infants in Tennessee, 2013-2017. Public Health Rep. 2022 Sep-Oct; 137(5):860-866.
    View in: PubMed
    Score: 0.007
  81. Association between punitive policies and neonatal abstinence syndrome among Medicaid-insured infants in complex policy environments. Addiction. 2022 01; 117(1):162-171.
    View in: PubMed
    Score: 0.007
  82. Prescription Opioid Dose After Vaginal Delivery and the Risk of Serious Opioid-Related Events: A Retrospective Cohort Study. Womens Health Issues. 2021 Jul-Aug; 31(4):376-383.
    View in: PubMed
    Score: 0.006
  83. Variation in discharge opioid prescribing after vaginal births. Am J Obstet Gynecol MFM. 2021 03; 3(2):100298.
    View in: PubMed
    Score: 0.006
  84. Antenatal Admissions Among Women with Opioid-Affected and Non-Opioid-Affected Deliveries. Matern Child Health J. 2020 Sep; 24(9):1179-1188.
    View in: PubMed
    Score: 0.006
  85. The state of the science in opioid policy research. Drug Alcohol Depend. 2020 09 01; 214:108137.
    View in: PubMed
    Score: 0.006
  86. Opioid Prescribing After Childbirth and Risk for Serious Opioid-Related Events: A Cohort Study. Ann Intern Med. 2020 09 01; 173(5):412-414.
    View in: PubMed
    Score: 0.006
  87. Outcomes, Resource Use, and Financial Costs of Unplanned Extubations in Preterm Infants. Pediatrics. 2020 06; 145(6).
    View in: PubMed
    Score: 0.006
  88. Well-Child Care Adherence After Intrauterine Opioid Exposure. Pediatrics. 2020 02; 145(2).
    View in: PubMed
    Score: 0.006
  89. Association of Punitive and Reporting State Policies Related to Substance Use in Pregnancy With Rates of Neonatal Abstinence Syndrome. JAMA Netw Open. 2019 11 01; 2(11):e1914078.
    View in: PubMed
    Score: 0.006
  90. Association of Antipsychotic Treatment With Risk of Unexpected Death Among Children and Youths. JAMA Psychiatry. 2019 02 01; 76(2):162-171.
    View in: PubMed
    Score: 0.006
  91. Neonatal abstinence syndrome. Nat Rev Dis Primers. 2018 11 22; 4(1):47.
    View in: PubMed
    Score: 0.005
  92. Delivery type, opioid prescribing, and the risk of persistent opioid use after delivery. Am J Obstet Gynecol. 2019 04; 220(4):405-407.
    View in: PubMed
    Score: 0.005
  93. Maternal Health in the United States. N Engl J Med. 2018 02 08; 378(6):587.
    View in: PubMed
    Score: 0.005
  94. Decision Science Can Help Policymakers to Identify and Evaluate Policies to Treat Opioid Use Disorder Among Pregnant Women. Womens Health Issues. 2018 Jan - Feb; 28(1):2-5.
    View in: PubMed
    Score: 0.005
  95. Pregnancy Intention and Maternal Alcohol Consumption. Obstet Gynecol. 2017 04; 129(4):727-733.
    View in: PubMed
    Score: 0.005
  96. Variation in inpatient tonsillectomy costs within and between US hospitals attributable to postoperative complications. Med Care. 2013 Dec; 51(12):1048-54.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.